Phase 2 clinical study· 2013

ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density

Dahan A|et al.

Molecular Medicine

DOI: 10.2119/molmed.2013.00122
PubMed: 24136731
Evidence level: moderate
Verification: verified

Summary

Clinical study evaluating symptoms and corneal nerve fibres in sarcoidosis.

Limitations

Small exploratory study|Surrogate nerve-fibre outcomes|Needs larger confirmation

Linked peptides

ARA-290

Important PeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.